YIELD10 BIOSCIENCE, INC. (NASDAQ:YTEN) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition
|
Item 9.01. Financial Statements and Exhibits
|
|
INDEX TO EXHIBITS
|
|
EXHIBIT 99.1
|
release announcing the financial results for its year ended
December 31, 2016. A copy of the press release is attached hereto
as Exhibit 99.1. This information, including Exhibit 99.1, shall
not be deemed filed for purposes of Section 18 of the Exchange
Act, or incorporated by reference in any filing under the
Securities Act or the Exchange Act, except as shall be expressly
set forth by specific reference in such a filing.
|
Exhibit
|
||
|
No.
|
Description
|
|
|
99.1
|
Press Release dated March 22, 2017.
|
About YIELD10 BIOSCIENCE, INC. (NASDAQ:YTEN)
Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn. The Company concentrates on technologies that enables it to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter. The Company has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada. YIELD10 BIOSCIENCE, INC. (NASDAQ:YTEN) Recent Trading Information
YIELD10 BIOSCIENCE, INC. (NASDAQ:YTEN) closed its last trading session up +0.003 at 0.388 with 12,365 shares trading hands.
